PAM
KZR

Panagora Asset Management’s Kezar Life Sciences KZR Stock Holding History

Panagora Asset Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,321
Closed -$210K – 1250
2024
Q1 		$210K Buy
23,321
+14,912
+177% +$136K ﹤0.01% 1150
2023
Q4 		$79.7K Buy
+8,409
New +$73.9K ﹤0.01% 1207
2021
Q3 		– Sell
-169
Closed -$9K – 2067
2021
Q2 		$9K Sell
169
-8
-5% -$454 ﹤0.01% 2298
2021
Q1 		$11K Hold
177
– – ﹤0.01% 2384
2020
Q4 		$9K Sell
177
-97
-35% -$5.4K ﹤0.01% 2314
2020
Q3 		$13K Sell
274
-302
-52% -$14.4K ﹤0.01% 2283
2020
Q2 		$30K Hold
576
– – ﹤0.01% 2079
2020
Q1 		$25K Buy
576
+469
+438% +$19.1K ﹤0.01% 1998
2019
Q4 		$4K Buy
+107
New +$3.29K ﹤0.01% 2286

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Panagora Asset Management's KZR Position: Q2 2024 in Review

Panagora Asset Management sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 23,321 shares — an estimated $210K sold.

Panagora Asset Management first reported a position in KZR in Q4 2019 and held it in 9 quarters. The position peaked at $210K in Q1 2024. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Panagora Asset Management reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Panagora Asset Management sold 23,321 Kezar Life Sciences shares in Q2 2024, an estimated $210K.
  • Panagora Asset Management first reported a position in Kezar Life Sciences in Q4 2019 and held it in 9 quarters.
  • Panagora Asset Management's Kezar Life Sciences position peaked at $210K in Q1 2024.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Panagora Asset Management's 13F filing for Q2 2024, filed 29 Jul 2024.